The U.S. concierge medicine market size is estimated at USD 6.14 billion in 2024, grew to USD 6.55 billion in 2025 and is predicted to surpass around USD 11,97 billion by 2034, expanding at a CAGR of 6.88% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Concierge Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Concierge Medicine Market Revenue and Volume, by Application, 2024-2034
8.1.1. Primary Care
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Cardiology
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Pediatrics
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. Psychiatry
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Internal Care
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
9.1. U.S. Concierge Medicine Market Revenue and Volume, by Ownership, 2024-2034
9.1.1. Independent
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Group
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. U.S.
10.1.1. Market Revenue and Volume Forecast, by Application (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by Ownership (2021-2034)
11.1. Priority Physicians, Inc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Castle Connolly Private Health Partners
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Partner MD
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Concierge Consultants and Cardiology
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client